References
- Bohnert AS, Walton MA, Cunningham RM, Ilgen MA, Barry K, Chermack ST, Blow FC. Overdose and adverse drug event experiences among adult patients in the emergency department. Addict Behav. 2018;1:66–72. doi:https://doi.org/10.1016/j.addbeh.2017.11.030.
- Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. JAMA. 2017;318:2295–96. doi:https://doi.org/10.1001/jama.2017.15971.
- Substance Abuse Mental Health and Services Administration. National survey on drug use and health: detailed tables. Rockford: SAMHSA; 2017 [accessed 2019 July 9]. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdf.
- Alexander M, Barbieri M, Kiang M. Opioid deaths by race in the United States, 2000–2015. In Population Association of America Meetings; 2017; Chicago. p. 27–29.
- Plunk AD, Grucza RA, Peglow SL. It is past time to think more inclusively about “deaths of despair”. Am J Bioeth. 2018;18:29–31. doi:https://doi.org/10.1080/15265161.2018.1513594.
- Shiels MS, Freedman ND, Thomas D, de Gonzalez AB. Trends in US drug overdose deaths in non-Hispanic black, Hispanic, and non-Hispanic white persons, 2000–2015. Ann Intern Med. 2018;168:453–55. doi:https://doi.org/10.7326/M17-1812.
- Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159:592–600. doi:https://doi.org/10.7326/0003-4819-159-9-201311050-00005.
- Brinkley-Rubinstein L, Zaller N, Martino S, Cloud DH, McCauley E, Heise A, Seal D. Criminal justice continuum for opioid users at risk of overdose. Addict Behav. 2018;86:104–10. doi:https://doi.org/10.1016/j.addbeh.2018.02.024.
- Eisenberg MD, Saloner B, Krawczyk N, Ferris L, Schneider KE, Lyons BC, Weiner JP. Use of opioid overdose deaths reported in one state’s criminal justice, hospital, and prescription databases to identify risk of opioid fatalities. JAMA Intern Med. 2019;179:980–82. doi:https://doi.org/10.1001/jamainternmed.2018.8757.
- Merrall EL, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, Hutchinson SJ, Bird SM. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010;105:1545–54. doi:https://doi.org/10.1111/j.1360-0443.2010.02990.x.
- Jonas AB, Young AM, Oser CB, Leukefeld CG, Havens JR. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med. 2012;74:1602–09. doi:https://doi.org/10.1016/j.socscimed.2011.12.053.
- Moody LN, Satterwhite E, Bickel WK. Substance use in rural Central Appalachia: current status and treatment considerations. Rural Ment Health. 2017;41:123. doi:https://doi.org/10.1037/rmh0000064.
- National Institute on Drug Abuse. Opioid summaries by state. 2019 May 22 [accessed 2019 Oct 12]. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state.
- Slavova S, Costich JF, Bunn TL, Luu H, Singleton M, Hargrove SL, Triplett JS, Quesinberry D, Ralston W, Ingram V. Heroin and fentanyl overdoses in Kentucky: epidemiology and surveillance. Int J Drug Policy. 2017;46:120–29. doi:https://doi.org/10.1016/j.drugpo.2017.05.051.
- Staton M, Ciciurkaite G, Havens J, Tillson M, Leukefeld C, Webster M, Oser C, Peteet B. Correlates of injection drug use among rural Appalachian women. J Rural Health. 2018;34:31–41. doi:https://doi.org/10.1111/jrh.12256.
- Faryar KA, Freeman CL, Persaud AK, Furmanek SP, Guinn BE, Mattingly WA, Wiemken TL, Buckner KA, Huecker MR. The effects of Kentucky’s comprehensive opioid legislation on patients presenting with prescription opioid or heroin abuse to one urban emergency department. J Emerg Med. 2017;53:805–14. doi:https://doi.org/10.1016/j.jemermed.2017.08.066.
- Ball JC, Shaffer JW, Nurco DN. The day to-day criminality of heroin addicts in Baltimore – a study in the continuity of offence rates. Drug Alcohol Depend. 1983;12:119–42. doi:https://doi.org/10.1016/0376-8716(83)90037-6.
- Borders TF, Wen H. Illicit drug and opioid use disorders among non-metropolitan residents. Lexington (KY): Rural and Underserved Health Research Center; 2018.
- Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821–26. doi:https://doi.org/10.1001/jamapsychiatry.2014.366.
- Habecker P, Welch-Lazoritz M, Dombrowski K. Rural and urban differences in nebraskans’ access to marijuana, methamphetamine, heroin, and prescription pills. J Drug Issues. 2018;48:608–24. doi:https://doi.org/10.1177/0022042618786717.
- Havens JR, Young AM, Havens CE. Nonmedical prescription drug use in a nationally representative sample of adolescents: evidence of greater use among rural adolescents. Arch Pediatr Adolesc Med. 2011;165:250–55. doi:https://doi.org/10.1001/archpediatrics.2010.217.
- Jalal H, Buchanich JM, Roberts MS, Balmert LC, Zhang K, Burke DS. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018;361:eaau1184. doi:https://doi.org/10.1126/science.aau1184.
- Eller R. Uneven ground: Appalachia since 1945. Lexington: University Press of Kentucky; 2008.
- Havens JR, Oser CB, Leukefeld CG, Webster JM, Martin SS, O’Connell DJ, Surratt HL, Inciardi JA. Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J Drug Alcohol Abuse. 2007;33:309–17. doi:https://doi.org/10.1080/00952990601175078.
- Kentucky Cabinet for Health and Family Services. Kentucky all schedule prescription electronic reporting – cabinet for health and family services. 2019 [accessed Jan 9 2019]. https://chfs.ky.gov/agencies/os/oig/dai/deppb/Pages/kasper.aspx.
- Luu H, Slavova S, Freeman PR, Lofwall M, Browning S, Bush H. Trends and patterns of opioid analgesic prescribing: regional and rural-urban variations in Kentucky from 2012 to 2015. J Rural Health. 2019;35:97–107. doi:https://doi.org/10.1111/jrh.12300.
- Bureau of Justice Statistics. Probation and parole in the United States, 2016. 2018 [accessed Jan 9 2019]. https://www.bjs.gov/content/pub/pdf/ppus16.pdf.
- Prison Policy Initiative. States of incarceration: the global context | prison policy initiative. 2019 [accessed Nov 6 2019]. https://www.prisonpolicy.org/global/2018.html.
- Hall MT, Ball D, Sears J, Higgins GE, Logan TK, Golder S. Past-year nonmedical use of prescription drugs among women on probation and parole: a cross-sectional study. Subst Abus. 2018;39:280–85. doi:https://doi.org/10.1080/08897077.2018.1442382.
- Staton M, Ciciurkaite G, Oser C, Tillson M, Leukefeld C, Webster JM, Havens JR. Drug use and incarceration among rural Appalachian women: findings from a jail sample. Subst Use Misuse. 2018;53:931–41. doi:https://doi.org/10.1080/10826084.2017.1385631.
- Staton M, Leukefeld C, Webster JM. Substance use, health, and mental health: problems and service utilization among incarcerated women. Int J Offender Ther Comp Criminol. 2003;47:224–39. doi:https://doi.org/10.1177/0306624X03251120.
- Smith KE, Staton M. Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: are synthetic cannabinoids actually preferred to other drugs? Subst Abus. 2018;7:1–10. doi:https://doi.org/10.1080/08897077.2018.1528495.
- Kentucky Department of Corrections. ASK - Department of Corrections. 2019 [accessed Oct 12 2019]. https://corrections.ky.gov/Divisions/ask/pages/default.aspx.
- Krawczyk N, Picher CE, Feder KA, Saloner B. Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Aff. 2017;36:2046–53. doi:https://doi.org/10.1377/hlthaff.2017.0890.
- Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, Friedmann PD. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005;82:411–19. doi:https://doi.org/10.1093/jurban/jti072.
- Carroll JJ, Marshall BD, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017;46:136–45. doi:https://doi.org/10.1016/j.drugpo.2017.05.023.
- Ruhm CJ. Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999–2015. Addiction. 2018;113:1339–44. doi:https://doi.org/10.1111/add.14144.
- Ruhm CJ. Drivers of the fatal drug epidemic. J Health Econ. 2019;64:25–42. doi:https://doi.org/10.1016/j.jhealeco.2019.01.001.
- Zoorob M. Fentanyl shock: the changing geography of overdose in the United States. Int J Drug Policy. 2019;70:40–46. doi:https://doi.org/10.1016/j.drugpo.2019.04.010.
- Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48:135–41. doi:https://doi.org/10.1016/S0376-8716(97)00117-8.
- Buer LM, Leukefeld CG, Havens JR. “I’m Stuck”: women’s navigations of social networks and prescription drug misuse in central Appalachia. North Am Dialogue. 2016;19:70–84. doi:https://doi.org/10.1111/nad.12044.
- Berridge KC, Aldridge JW. Special review: decision utility, the brain, and pursuit of hedonic goals. Soc Cog. 2008;26:621–46. doi:https://doi.org/10.1521/soco.2008.26.5.621.
- Hyman SM, Fox H, Hong KI, Doebrick C, Sinha R. Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. Exp Clin Psychopharmacol. 2007;15:134. doi:https://doi.org/10.1037/1064-1297.15.2.134.
- Mumola CJ, Karberg JC. Drug use and dependence, state and federal prisoners, 2004. Washington (DC): US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2006. p. 1–12.
- Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacol. 2003;170:62–72. doi:https://doi.org/10.1007/s00213-003-1525-8.
- Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu Rev Clin Psychol. 2014;10:641–77. doi:https://doi.org/10.1146/annurev-clinpsy-032813-153724.
- Petry M, Tedford J, Martin B. Reinforcing compliance with non-drug–related activities. J Subst Abuse Treat. 2001;20:33–44. doi:https://doi.org/10.1016/S0740-5472(00)00143-4.
- Heilig M, Epstein DH, Nader MA, Shaham Y. Time to connect: bringing social context into addiction neuroscience. Nat Rev Neurosci. 2016;17:592. doi:https://doi.org/10.1038/nrn.2016.67.
- Moore K, Stuewig J, Tangney J. Jail inmates’ perceived and anticipated stigma: implications for post-release functioning. Self Identity. 2013;12:527–47. doi:https://doi.org/10.1080/15298868.2012.702425.
- LeBel TP. Invisible stripes? Formerly incarcerated persons’ perceptions of stigma. Deviant Behav. 2012;33:89–107. doi:https://doi.org/10.1080/01639625.2010.538365.
- Meit M, Heffernan M, Tanenbaum E, Hoffmann T. Appalachian diseases of despair. Report for the Appalachian Regional Commission. Bethesda, MD: The Walsh Center for Rural Health Analysis National Opinion Research Center (NORC) at the University of Chicago; 2017.
- Monnat SM. Deaths of despair from the cities to the hollers: explaining spatial differences in US drug, alcohol, and suicide mortality rates; Paper prepared by the Population Research Institute at Pennsylvania State University for the 2017 Population Association of America Annual Meeting; 2017; Chicago, IL.
- Dickson MF, Staton‐Tindall M, Smith KE, Leukefeld C, Webster JM, Oser CB. A Facebook follow-up strategy for rural drug-using women. J Rural Health. 2017;33:250–56. doi:https://doi.org/10.1111/jrh.12198.
- Staton M, Strickland JC, Webster JM, Leukefeld C, Oser C, Pike E. HIV prevention in rural appalachian jails: implications for re-entry risk reduction among women who use drugs. AIDS Behav. 2018;22:4009–18. doi:https://doi.org/10.1007/s10461-018-2209-z.
- McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9:199–213. doi:https://doi.org/10.1016/0740-5472(92)90062-S.
- McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, OʼBrien CP. New data from the addiction severity index reliability and validity in three centers. J Nerv Ment Dis. 1985;173:412–23. doi:https://doi.org/10.1097/00005053-198507000-00005.
- Haas AL, Peters RH. Development of substance abuse problems among drug-involved offenders: evidence for the telescoping effect. Subst Abus. 2000;12:241–53. doi:https://doi.org/10.1016/S0899-3289(00)00053-5.
- Jaffe A, Du J, Huang D, Hser YI. Drug-abusing offenders with comorbid mental disorders: problem severity, treatment participation, and recidivism. J Subst Abuse Treat. 2012;43:244–50. doi:https://doi.org/10.1016/j.jsat.2011.12.002.
- Wahler EA. Social disadvantage and economic hardship as predictors of follow-up addiction severity after substance abuse treatment: does referral to treatment by the criminal justice system matter? Alcohol Treat Q. 2015;33:6–27. doi:https://doi.org/10.1080/07347324.2015.982463.
- Zanis DA, McLellan AT, Corse S. Is the addiction severity index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Community Mental Health J. 1997;33:213–27. doi:https://doi.org/10.1023/A:1025085310814.
- U.S. Department of Agriculture. Measuring rurality: rural-urban continuum codes. United States Department of Agriculture Economic Research Service. 2013 [accessed Jun 1 2019]. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/documentation/.
- Appalachian Regional Commission. Research, maps, and data – appalachian regional commission. 2019 [accessed Feb 1 2019]. https://www.arc.gov/research/RegionalDataandResearch.asp.
- StataCorp. Stata Statistical Software: release 15. College Station (TX): StataCorp LLC; 2017.
- Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. J Subst Abuse Treat. 2005;28:189–96. doi:https://doi.org/10.1016/j.jsat.2004.12.005.
- McLellan AT, Lewis DC, O’brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–95. doi:https://doi.org/10.1001/jama.284.13.1689.
- Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacol. 2001;158:343–59. doi:https://doi.org/10.1007/s002130100917.
- Clarke JG, Martin RA, Gresko SA, Rich JD. The first comprehensive program for opioid use disorder in a US statewide correctional system. Am J Public Health. 2018. doi:https://doi.org/10.2105/AJPH.2018.304666.
- Rich JD, McKenzie M, Shield DC, Wolf FA, Key RG, Poshkus M, Clarke J. Linkage with methadone treatment upon release from incarceration: a promising opportunity. J Addict Dis. 2005;24:49–59. doi:https://doi.org/10.1300/J069v24n03_04.
- Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. J Subst Abuse Treat. 2013;45:222–26. doi:https://doi.org/10.1016/j.jsat.2013.02.005.
- Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373:1789–90. doi:https://doi.org/10.1056/NEJMc1505541.
- Evans WN, Lieber EM, Power P. How the reformulation of OxyContin ignited the heroin epidemic. Rev Econ Stat. 2019;101:1–5. doi:https://doi.org/10.1162/rest_a_00755.
- Lebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RC. Scoring the best deal: quantity discounts and street price variation of diverted oxycodone and oxymorphone. Pharmacoepidemiol Drug Saf. 2019;28:25–30. doi:https://doi.org/10.1002/pds.4558.
- Mallatt J. The effect of prescription drug monitoring programs on opioid prescriptions and heroin crime rates; 2018 [accessed Sep 13 2018]. Available at SSRN 3050692: https://ssrn.com/abstract=3050692.
- Bunting AM, Victor G III, Pike E, Staton M, Winston E, Pangburn K. The impact of policy changes on heroin and nonmedical prescription opioid use among an incarcerated population in Kentucky, 2008 to 2016. Crim Justice Policy Rev. 2019;1–17. doi:https://doi.org/10.1177/0887403419838029.
- Faryar KA, Ems TI, Bhandari B, Huecker MR. Prevalence of emergency department patients presenting with heroin or prescription opioid abuse residing in urban, suburban, and rural Jefferson county. J Emerg Med. 2018;55:605–11. doi:https://doi.org/10.1016/j.jemermed.2018.07.029.
- Hedegaard H, Miniño AM, Warner M. Urban–rural differences in drug overdose death rates, by sex, age, and type of drugs involved, 2017. Hyattsville (MD): National Center for Health Statistics; 2019. NCHS Data Brief, no 345.
- Keyes KM, Cerdá M, Brady JE, Havens JR, Galea S. Understanding the rural–urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104:e52–9. doi:https://doi.org/10.2105/AJPH.2013.301709.
- Cloud DH, Ibragimov U, Prood N, Young AM, Cooper HL. Rural risk environments for hepatitis c among young adults in Appalachian Kentucky. Int J Drug Policy. 2019;72:47–54. doi:https://doi.org/10.1016/j.drugpo.2019.05.006.
- John WS, Wu LT. Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015. Drug Alcohol Depend. 2017;180:376–84. doi:https://doi.org/10.1016/j.drugalcdep.2017.08.031.
- Schoeneberger ML, Leukefeld CG, Hiller ML, Godlaski T. Substance abuse among rural and very rural drug users at treatment entry. Am J Drug Alcohol Abuse. 2006;32:87–110. doi:https://doi.org/10.1080/00952990500328687.
- Borders TF, Booth BM, Stewart KE, Cheney AM, Curran GM. Rural/urban residence, access, and perceived need for treatment among African American cocaine users. J Rural Health. 2015;31:98–107. doi:https://doi.org/10.1111/jrh.12092.
- Shannon LM, Havens JR, Hays L. Examining differences in substance use among rural and urban pregnant women. Am J Addict. 2010;19:467–73. doi:https://doi.org/10.1111/j.1521-0391.2010.00079.x.
- Young AM, Havens JR, Leukefeld CG. A comparison of rural and urban nonmedical prescription opioid users’ lifetime and recent drug use. Am J Drug Alcohol Abuse. 2012;38:220–27. doi:https://doi.org/10.3109/00952990.2011.643971.
- Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007;827–40. doi:https://doi.org/10.1002/pds.1452.
- Inciardi JA, Cicero TJ. Black beauties, gorilla pills, footballs, and hillbilly heroin: some reflections on prescription drug abuse and diversion research over the past 40 years. J Drug Issues. 2009;39:101–14. doi:https://doi.org/10.1177/002204260903900109.
- Young AM, Havens JR, Leukefeld CG. Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct J. 2010;7:24. doi:https://doi.org/10.1186/1477-7517-7-24.
- Surratt HL, Staton M, Leukefeld CG, Oser CB, Webster JM. Patterns of buprenorphine use and risk for re-arrest among highly vulnerable opioid-involved women released from jails in rural Appalachia. J Addict Dis. 2018;37:1–4. doi:https://doi.org/10.1080/10550887.2018.1531738.
- Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131:263–70. doi:https://doi.org/10.1016/j.drugalcdep.2012.11.018.
- Guzman D, Ettenberg A. Heroin attenuates the negative consequences of cocaine in a runway model of self-administration. Pharmacol Biochem Behav. 2004;79:317–24. doi:https://doi.org/10.1016/j.pbb.2004.08.009.
- Jasinski DR, Preston KL. Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects. Drug Alcohol Depend. 1986;17:1–3. doi:https://doi.org/10.1016/0376-8716(86)90031-1.
- Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98:7–22. doi:https://doi.org/10.1046/j.1360-0443.2003.00236.x.
- Bonner RL, Rich AR. Psychosocial vulnerability, life stress, and suicide ideation in a jail population: a cross-validation study. Suicide Life Threat Behav. 1990;20:213–24. doi:https://doi.org/10.1111/j.1943-278X.1990.tb00106.x.
- Brinkley-Rubinstein L. Incarceration as a catalyst for worsening health. Health Justice. 2013;1:3. doi:https://doi.org/10.1186/2194-7899-1-3.
- Kaba F, Lewis A, Glowa-Kollisch S, Hadler J, Lee D, Alper H, Selling D, MacDonald R, Solimo A, Parsons A, et al. Solitary confinement and risk of self-harm among jail inmates. Am J Public Health. 2014;104:442–47. doi:https://doi.org/10.2105/AJPH.2013.301742.
- Austin AE, Proescholdbell SK, Creppage KE, Asbun A. Characteristics of self-inflicted drug overdose deaths in North Carolina. Drug Alcohol Depend. 2017;181:44–49. doi:https://doi.org/10.1016/j.drugalcdep.2017.09.014.
- Brådvik L, Frank A, Hulenvik P, Medvedeo A, Berglund M. Heroin addicts reporting previous heroin overdoses also report suicide attempts. Suicide Life Threat Behav. 2007;37:475–81. doi:https://doi.org/10.1521/suli.2007.37.issue-4.
- Heale P, Dietze P, Fry C. Intentional overdose among heroin overdose survivors. J Urban Health. 2003;80:230–37. doi:https://doi.org/10.1093/jurban/jtg026.
- Roxburgh A, Hall WD, Dobbins T, Gisev N, Burns L, Pearson S, Degenhardt L. Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug Alcohol Depend. 2017;179:291–98. doi:https://doi.org/10.1016/j.drugalcdep.2017.07.018.
- Flanagan O. Willing addicts? Drinkers, dandies, druggies, and other dionysians. In: Heather N, Segal G, eds. Addiction and choice: rethinking the relationship. New York, NY: Oxford University Press; 2016: 66–81.
- Pickard H, Ahmed SH. How do you know you have a drug problem? The role of knowledge of negative consequences in explaining drug choice in humans and rats. In: Heather N, Segal G, eds. Addiction and choice: rethinking the relationship. New York, NY: Oxford University Press; 2016: 29–48.
- Oquendo MA, Volkow ND. Suicide: a silent contributor to opioid-overdose deaths. N Engl J Med. 2018;378:1567–69. doi:https://doi.org/10.1056/NEJMp1801417.
- Waldorf D, Reinarman C, Murphy S. Cocaine changes: the experience of using and quitting. Philadelphia (PA): Temple University Press; 1992.
- Kahn K. Reconnecting work and health: a report from the 2017 Aspen institute economic security summit. The Aspen Institute. [accessed Apr 14 2019]. https://assets.aspeninstitute.org/content/uploads/2018/06/2018_ESS_Report_Web.pdf.
- Kunz-Ebrecht SR, Kirschbaum C, Steptoe A. Work stress, socioeconomic status and neuroendocrine activation over the working day. Soc Sci Med. 2004;58:1523–30. doi:https://doi.org/10.1016/S0277-9536(03)00347-2.
- Buck PD. Worked to the bone: race, class, power, and privilege in Kentucky. New York (NY): Monthly Review Press; 2001.
- Dalla RL, Xia Y, Kennedy H. “You just give them what they want and pray they don’t kill you” street-level sex workers’ reports of victimization, personal resources, and coping strategies. Violence Against Women. 2003;9:1367–94. doi:https://doi.org/10.1177/1077801203255679.
- Liu Y, Elliott AL, Striley CW, Gurka KK, Cottler LB. Motives for prescription stimulant use by patterns of non-medical use. J Subst Use. 2019;24:455–60. doi:https://doi.org/10.1080/14659891.2019.1604838.
- Travis LF III, Stacey J. A half century of parole rules: conditions of parole in the United States, 2008. J Crim Justice. 2010;38:604–08. doi:https://doi.org/10.1016/j.jcrimjus.2010.04.032.
- Carroll JJ, Rich JD, Green TC. The more things change: buprenorphine/naloxone diversion continues while treatment remains inaccessible. J Addict Med. 2018;12:459–65. doi:https://doi.org/10.1097/ADM.0000000000000436.
- Chilcoat HD, Amick HR, Sherwood MR, Dunn KE. Buprenorphine in the United States: motives for abuse, misuse, and diversion. J Subst Abuse Treat. 2019;104:148–57. doi:https://doi.org/10.1016/j.jsat.2019.07.005.
- Cicero TJ, Ellis MS, Chilcoat HD. Understanding the use of diverted buprenorphine. Drug Alcohol Depend. 2018;193:117–23. doi:https://doi.org/10.1016/j.drugalcdep.2018.09.007.
- Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998 Aug 1;51:253–63. doi:https://doi.org/10.1016/S0376-8716(98)00028-3.
- Denis C, Fatséas M, Beltran V, Bonnet C, Picard S, Combourieu I, Daulouède JP, Auriacombe M. Validity of the self-reported drug use section of the Addiction Severity Index and associated factors used under naturalistic conditions. Subst Use Misuse. 2012;47:356–63. doi:https://doi.org/10.3109/10826084.2011.640732.
- Zanis DA, McLellan AT, Randall M. Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend. 1994;35:127–32. doi:https://doi.org/10.1016/0376-8716(94)90119-8.
- Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E. Young adults’ opioid use trajectories: from nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addict Behav. 2018;86:118–23. doi:https://doi.org/10.1016/j.addbeh.2018.04.017.
- Morgan L, Weaver M, Sayeed Z, Orr R. The use of prescription monitoring programs to reduce opioid diversion and improve patient safety. J Pain Palliat Care Pharmacother. 2013;27:4–9. doi:https://doi.org/10.3109/15360288.2012.738288.
- Victor GA, Walker R, Cole J, Logan TK. Opioid analgesics and heroin: examining drug misuse trends among a sample of drug treatment clients in Kentucky. Int J Drug Policy. 2017;46:1–6. doi:https://doi.org/10.1016/j.drugpo.2017.01.008.
- Brownstein HH, Taylor BG. Measuring the stability of illicit drug markets: why does it matter? Drug Alcohol Depend. 2007;90:S52–60. doi:https://doi.org/10.1016/j.drugalcdep.2006.11.010.
- Furnari M, Epstein DH, Phillips KA, Jobes ML, Kowalczyk WJ, Vahabzadeh M, Lin J-L, Preston KL. Some of the people, some of the time: field evidence for associations and dissociations between stress and drug use. Psychopharmacology. 2015;232:3529–37. doi:https://doi.org/10.1007/s00213-015-3998-7.
- Alex B, Weiss DB, Kaba F, Rosner Z, Lee D, Lim S, Venters H, MacDonald R. Death after jail release: matching to improve care delivery. J Correctional Health Care. 2017;23:83–87. doi:https://doi.org/10.1177/1078345816685311.
- Brinkley-Rubinstein L, Zaller N, Martino S, Cloud DH, McCauley E, Heise A, Seal D. Criminal justice continuum for opioid users at risk of overdose. Addict Behav. 2018;86:104–10. doi:https://doi.org/10.1016/j.addbeh.2018.02.024.
- Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BD, Alexander-Scott N, Boss R, Rich JD. Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatry. 2018;75:405–07. doi:https://doi.org/10.1001/jamapsychiatry.2017.4614.